Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPCP for Depigmentation in Extensive Vitiligo
NCT04775979Phase 4Completed
- Sponsor
- Ain Shams University
- Start
- Jan 2021
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diphencyprone in Vitiligo, sponsored by Ain Shams University. Primary endpoint: Degree of Depigmentation at 6 weeks. Started Jan 2021; status: completed.
02
Drugs
diphencyprone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04775979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04775979.